Navigation Links
Program highlights from the upcoming meeting of the American Physiological Society

BETHESDA, Md. (March 18, 2013)The American Physiological Society (APS) is one of six scientific societies sponsoring the meeting Experimental Biology 2013 (EB 2013), being held April 20-24, 2013 at the Boston Convention and Exhibition Center (BCEC), in Boston, Mass. The APS has programmed some 2,700 scientific abstracts for this year's meeting and dozens of symposia. Program highlights, with times and locations include:

Nobel Laureate in Physiology or Medicine Lecture:

Unraveling Smell: How are we able to differentiate between smells? How does the brain remember them? Nobel Laureate Linda Buck, Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, Wash., went looking for answers. In 2004 she, along with Richard Axel, was awarded the Nobel Prize in Physiology or Medicine for work on olfactory receptors. Dr. Buck will deliver this year's Laureate lecture as part of the APS's annual meeting. (Wednesday, April 24, 4:45 p.m. Location: BCEC, 210BC)

New Experimental Approaches to Human Brain Function in Health and Disease:

The last decade has seen an explosion in discoveries about the brain. This symposium brings together four nationally recognized experts in brain research who approach a variety of human brain functions and disorders throughout the lifespan from: early brain development and the evolution of human cognition and its maldevelopment in idiopathic mental retardation; to how the human brain makes decisions in health and in diseases such as Parkinson's disease; to the analysis of neurotransmission and neuromodulation in adult psychiatric disease; to the study of cellular and signaling processes in schizophrenia and bipolar disorder. (Sunday, April 21, 8 a.m. Location: BCEC, 208)

Eating Disorders:

The first cases of anorexia nervosa (AN) and bulimia nervosa (BN) were diagnosed more than 80 years ago; binge-eating disorder (BED) was first recorded in 1959. These most deadly of psychiatric disorders are not easily understood and treatment protocols are often found wanting. However a shift has recently occurred to understand eating disorders as biological conditions. Four lectures in this symposium will offer a discussion of how the use of animal models has resulted in novel mechanisms and treatment targets for possible use in understanding and ultimately treating these disorders. (Tuesday, April, 23, 3:15 p.m. Location: BCEC, 210BC) (Note: Part of the program, Physiology In Focus: From Animals to Human Models of Disease)

Sex-Based Differences in Exercise Metabolism:

Men and women are certainly different, and those differences are readily apparent in each gender's physiological response to exercise. Four lectures will address how differences in male and female metabolism, both during and after exercise based on other factors, can be linked to differences in body composition, insulin sensitivity, and inflammation. Attendees will take away from this symposium an up-to-date view of the sex-based differences in various aspects of metabolismfat, protein, and post-exercise recoveryand be able to link this into a comparative view of how men and women adapt to various forms of chronic exercise training. (Wednesday, April, 24, 10:30 a.m. Location: BCEC, 206A)

Emerging Concepts in Understanding Mechanisms of Diabetes:

The Diabetes Health Center reports that more than half of all Americans may develop diabetes or prediabetes by 2020 unless prevention strategies aimed at weight loss and increased physical activity are widely implemented. Key to prevention is effective research and the five lectures in this symposium will address kidney function, endocrine function and insulin resistance, cardiac and vascular function, role of muscle mass in insulin resistance, cell physiology and adipogenesis, and stem cell differentiation. This session will provide new insights and emerging concepts about the pathology of obesity and diabetes on many different physiological systems. (Wednesday, April 24, 2:30 p.m. Location: BCEC, 2l0A)

Animal Models of the Irritable Bowel Syndrome:

Basic and Translational Implications: It is not clear why patients develop irritable bowel syndrome (IBS). Currently there is no cure for the disease, only treatment designed to alleviate symptoms. One challenge for the development of novel and effective treatments is the lack of animal models that recapitulate all aspects of IBS. This symposium, comprised of four lectures, will address how recent animal research has contributed to our understanding of IBS and the development of new treatment strategies. (Sunday, April 21, 3:15 p.m. Location: BCEC, 210BC) (Note: Part of the program, Physiology In Focus: From Animals to Human Models of Disease)

The Role of Psychological Stress and Depression in Determining Cardiovascular Disease Risk The Use of Animal Models and Clinical Applications:

This symposium brings together clinical and basic science researchers who examine the role of stress and depression on cardiovascular disease (CVD) development as well as the impact of inflammation. Lecturers are international experts in the fields of cardiovascular behavioral medicine, vascular biology, psychoneuroimmunology, and stress neurobiology. The six lectures will address the role of the renin angiotensin system (the hormonal system that regulates blood pressure and water in the brain during stress), the impact of early life stress on cerebral vascular function, the role of inflammation as well as clinical studies and treatments centered on stress, and depression and CVD risk. (Wednesday, April 24, 8 a.m. Location: BCEC, 205C)

Lessons from New Animal Models of Cystic Fibrosis:

Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States. The disease is caused by a mutation in the gene that encodes a protein called cystic fibrosis transmembrane conductance regulator (CFTR), which functions as a chloride channel at the surface of airways and moves chloride out of the cells. This symposium will explore how new animal research has produced novel models that recapitulate key features of CF disease, providing new insights into how CTFR gene disruption occurs and informing new therapeutic thinking that may lead to new treatments. (Monday, April, 22, 3:15 p.m. Location: BCEC, 210BC) (Note: Part of the program, Physiology In Focus: From Animals to Human Models of Disease)


Contact: Donna Krupa
American Physiological Society

Related biology news :

1. Epigenetic signatures direct the repair potential of reprogrammed cells
2. An integrated pest management program for coffee berry borer in Colombia
3. UCSB researchers to examine the effects of year-old NOAA West Coast Catch Shares program
4. UCSF artificial kidney project tapped for accelerated FDA program
5. SeaSketch, the next generation of UCSBs MarineMap program, will aid marine spatial planning
6. DFG establishes 10 new priority programs
7. Wells Fargo fosters environmental conservation through University of Miamis RJD program
8. Heart Damage Repaired By Reprogramming Resident Fibroblasts into Functioning Heart Cells
9. Scientists identify first gene in programmed axon degeneration
10. Grant program to spur new research on Alzheimers disease by encouraging collaboration
11. Research: Many programs to help diabetics manage their health do work
Post Your Comments:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)...  Vigilant Solutions announces today that Mr. Dick ... --> --> Mr. ... partnership at TPG Capital, one of the largest global ... in revenue.  He founded and led TPG,s Operating Group, ... from 1997 to 2013.  In his first role, he ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. (CSBR), ... services to personalize the development and use of oncology ... Executive Officer, will be presenting at the LD MICRO ... Pacific Standard Time (PST).  The conference, held at the ... Angeles, CA , will feature 200 small/micro-cap companies ...
(Date:11/30/2015)... 2015  HUYA Bioscience International, the leader in accelerating ... innovations, today announced it has signed a Memorandum of ... foster collaboration between KDDF and HUYA with the ultimate ... products for the global market. ... new innovative preclinical and clinical stage compounds. The company ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
Breaking Biology Technology: